REFERENCES
- Larsen PR, Kronenberg HM, Melmed S, Polonsky KS. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders, 2003: 637–8.
- van Kasteren YM, Schoemaker J. Premature ovarian failure: a systematic review on therapeutic interventions to restore ovarian function and achieve pregnancy. Hum Reprod Update 1999;5:483–92.
- Meskhi A, Seif MW. Premature ovarian failure. Curr Opin Obstet Gynecol 2006;18:418–26.
- The Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea. Fertil Steril 2006;86 (Suppl 4):148–55.
- Burger HG. Androgen production in women. Fertil Steril 2002;77 (Suppl 4):S3–5.
- Casson PR, Lindsay MS, Pisarska MD, Carson SA, Buster JE. Dehydroepiandrosterone supplementation augments ovarian stimulation in poor responders: a case series. Hum Reprod 2000;15:2129–32.
- Casson PR, Santoro N, Elkind-Hirsch K, Carson SA, Hornsby PJ, Abraham G, et al. Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril 1998;70: 107–10.
- Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006;21:2845–9.
- Mamas L. Comparison of fallopian tube sperm perfusion and intrauterine tuboperitoneal insemination: a prospective study. Fertil Steril 2006;85:735–40.
- Anasti JN. Premature ovarian failure. Fertil Steril 1998;70:1–15. Fertility
